Cover Conference-at-a-Glance Annual STRATEGIC ALLIANCECorporate Development Project Management...

Advancing Pharmaceuticals through Collaborations & Partnerships

• Connect with 100+ Attendees with Dedicated Networking Sessions

• Listen to 20+ Expert Presentations and Interactive Panels

• Discuss Challenges in AM during Informal Roundtables

• Attend Conference Workshops for In-Depth Training

• Learn from Real-World Case Studies and Co-Presentations

KEYNOTE SPEAKERSEVENT FEATURES

Premier Sponsor

11th Annual

ALLIANCE STRATEGIC

MANAGEMENT CONGRESS

May 5-7, 2014Loews Philadelphia HotelPhiladelphia Downtown

“This is THE educational conference that all alliance management professionals need to attend to keep up with the latest trends and technologies in alliance management.” - Director Alliance Management, Aveva Drug Delivery Systems

Alliance Evolution: From Just Signing a License to Getting Beyond the DealFrank Grams, Ph.D., Vice President, Head, Alliance Management & Transactions, Sanofi

AbbVie, a New Type of Company; a New Model for Alliance ManagementAnna Maroney, Ph.D., Vice President, Head, Alliance Management, AbbVie

Building an Alliance Management Culture and Capabilities within Your Company - It Goes a Long Way to Foster Healthy Collaborations and to Be a Preferred PartnerKnut Sturmhoefel, Ph.D., Head, Alliance Management, Global Business Development & Licensing, Novartis

Corporate Sponsor

Cover

Agenda

Sponsor & Exhibit Opportunities

Conference-at-a-Glance

REGISTER NOW

Hotel & Travel Information

Short Courses

Registration Information

Click Here to Register Online!Healthtech.com/AMS

Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, MA 02494www.healthtech.com 1

Connect on LinkedInALLIANCEMANAGEMENT& BUSINESSDEVELOPMENT NETWORK

http://chidb.com/register/2014/ams/reg.asp

http://www.healthtech.com/ams

http://www.healthtech.com

http://www.linkedin.com/groups?gid=1895301&trk=my_groups-b-grp-v

Within the biopharmaceutical industry there is a growing emphasis on alliances and collaboration with external organizations driven by the need to access innovation, fill product pipelines, develop companion diagnostics, and ultimately, harness an alliance ecosystem to gain market access. Yet, despite the impetus to forge strategic partnerships, stakeholders are often confronted with the increasing complexities of systematically and effectively managing partnerships throughout their lifecycle. Why do some alliances fail, while others bear fruit? How do partnering companies create a shared culture, develop trust, and maximize their investments? How does the alliance management function itself act as a central driver of value, while alleviating perturbations, and meeting alliance goals? Critical to the success of any strategic partnership is the ever evolving discipline of alliance management.

Cambridge Healthtech Institute’s 11th Annual Strategic Alliance Management Congress, May 5-7, brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and to identify the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.

11th Annual

ALLIANCE STRATEGIC

MANAGEMENT CONGRESS

Advancing Pharmaceuticals through Collaborations & Partnerships

Cover

Agenda



REGISTER NOW


Short Courses





Hear from an Expert Speaking Faculty Including Representatives from:AbbVieAstraZenecaBlood Centers of AmericaBristol-Myers SquibbCook General BiotechnologiesEmergent BiosolutionsFDAHIKMA PharmaceuticalsMerckNovartis

Reata PharmaceuticalsRegenerexSanofiSelventaSRI InternationalTerumo BCTThe Leukemia & Lymphoma Soc (LLS)University of California, San DiegoUniversity of PennsylvaniaVantage Partners

Who Should AttendYear over year, strategists in Pharma, Biotech, Medical Devices, Diagnostics, Academic/Government Research Centers, Venture Capitals, CROs, Related Solutions/Services benefit from the insight and connections delivered at the Strategic Alliance Management Congress, providing a must-attend event for teams in:Alliance ManagementBusiness ManagementCorporate DevelopmentProject ManagementExternal Scientific AffairsOperations/General ManagementLicensingTechnology Transfer

Attendee Profile

View the2013 Alumni

COMPANY TYPEn Pharmaceutical 41%n Biotechnical 34%n Services 7%n Academic/Tech Transfer 5%n CRO 4%n Financial 4%

n Hospital 3%n Government 2%

TITLEn Director 43%n Executive 19%n Manager 17%n Sales & Marketing 11%n Scientist/Technologist 8%n Other 2%

LOCATIONn US 79%*n Europe 18%n Other 3%

* East Coast 74% West Coast 14% Midwest 12%





http://www.healthtech.com/Conferences_Overview.aspx?id=131510&libID=131458

“The congress is the best event for alliance managers to collaborate and learn best practices.” - Division Head, RUSNANO

WEB PARTNERS

LEAD SPONSORING PUBLICATIONS SPONSORING PUBLICATIONS

PREMIER SPONSOR

CORPORATE SPONSOR

Monday, May 5

Being a World-Class Alliance Manager: Sponsored by The Key Behavioral Tools that All Alliance Managers Need to MasterBeing an alliance manager is hard and complicated work. They are called on to align folks with competing interests, intervene where emotions are strong, facilitate where there are multiple parties involved, and ultimately be effective where others have failed. Most alliance managers rely on their intuition and experience to do this, often without any key tools, frameworks or methodologies. In this workshop, the alliance manager will be introduced to and trained on an alliance management toolkit that they can use in their day to day complex context to be more confident, more effective, and ultimately more valuable in their role.Instructor:Patrick Mascia, Consultant, Vantage PartnersTopics to be Covered:• Why alliances are particularly challenging• What a good outcome of an intervention in an alliance issue entails• A set of tools for overcoming challenges and reaching that good outcome

Tuesday, May 6

Maximizing the Potential of Academic-Industry Partnerships: Lessons for Scientific Innovation, Creative Partnership Models, and Systematic ManagementDrug development has approached a critical junction where the escalating costs of R&D combined with an urgent need for the delivery of novel, transformative therapies has motivated developers to harness the ground-breaking discoveries and basic research derived from academic medical centers, by forging strategic partnerships to fill development pipelines. With this increase in the academic-industry collaboration, stakeholders require innovative strategies to mitigate common challenges of establishing appropriate deal structures for cultivating collaborative environments; data and resource sharing; intellectual property rights; conflicts in culture; mutual understanding of goals, responsibilities and governance; and managing academic partnerships as integral components to industry portfolios. This workshop will showcase best practices from a series of academic and industry alliance leaders to discuss opportunities for refining academic-industry partnerships to maximize their inherent potential.Instructors:Simon Bateman, Ph.D., Executive Director, Global Strategic Alliance Management, Novartis OncologyDana M. Hammill, Director, Alliance Management, Translational Research Program, University of PennsylvaniaRathnam Chaguturu, Ph.D., Founder & CEO, iDDPartners; Senior Director, Discovery Sciences, SRI InternationalTammy Heesakker, Senior Business Strategy & Licensing Manager, Innovation, Partners HealthCare

*Separate registration required

SHORT COURSE*PRE-CONFERENCE SHORT COURSE*DINNERCover

Agenda



REGISTER NOW


Short Courses









Day 1 - MONDAY, MAY 5

8:00 am Registration and Morning Coffee

9:00 Pre-Conference Short Course (See details page 3)*

12:00 pm Conference Registration

An AM Update: Insights into Biopharma Alliances

1:25 Chairperson’s Opening RemarksStuart Kliman, J.D., Partner, Vantage Partners

1:30 Where Is Alliance Management Now: The Sponsored by Vantage Partners Latest Survey of AM Approaches and Best PracticesStuart Kliman, J.D., Partner, Vantage PartnersOver the last 6 months Vantage has engaged in a comprehensive cross-industry study of the current state of Alliance Management. In this discussion Vantage will for the first time present key aspects of its findings as those pertain to the biotech and pharmaceutical industry.

From the Ground Up: Building and Continuously Improving (True) Alliance Capability

2:15 Co-Presentation: Initiating a Joint Approach towards Building a Strong Alliance Management CapabilityEric M. Falcand, Director, Alliance Management & US Licenses, Servier MondeCatherine Rochat, Director, R&D Alliance Management, Institut de Recherches Internationales Servier (IRIS)Implementing effective partnerships become more acute when partnering activities are on the rise. This presentation will review how a joint approach initiated by Business Development and R&D teams has contributed to the actual building of a new organizational structure to successfully manage various types of alliances in line with the company’s culture. On this journey, not only new tools, processes and trainings have been incorporated, but a collaborative spirit was absorbed in this effort aiming at building a true and effective alliance capability. The benefits of such implementation for the company will be reviewed through some concrete examples.

2:45 Building Capabilities with Diverse RelationshipsAngus Grant, Vice President, Business Development & Global Alliances, Celgene Corporation

3:15 Improving Your Company Alliance CapabilityKaren Denton, Director, Alliance Management, Bayer Health Care PharmaceuticalsPartnering effectively means being able to continually improve your alliance capability. This presentation will look at a variety of different methodologies for assessing alliance capability and then a framework for looking at different areas of that capability - Strategic — Extent to which the company is oriented for partnering success; Operational — Extent to which the capabilities and processes to support effective joint alliance execution and Mindset/Culture — Extent to which leadership and incentives ensure the appropriate behaviors. An implementation plan for improvement will be discussed with practical examples for building on strengths and managing weaknesses.

3:45 Coffee Break in the Exhibit Hall

Tackling Partnership Complexities: Managing and Expanding a Diverse Portfolio

4:15 Integration Management - The Next Frontier for Alliance Management?Nick Dunscombe, Head, Global Alliance Management, Centre of Excellence, AstraZenecaThis presentation will summarize the work within AstraZeneca to establish a central integration management capability. This is built upon a similar model for alliance management and harnesses similar skills and capabilities.

4:45 Deploying AM Resources across a Dynamic Alliance PortfolioMichael Iafolla Jr., Vice President, Alliance Management, Bristol-Myers SquibbAs companies become more reliant on partnering, alliance portfolio management increases in importance. The portfolio can vary from early stage to late stage assets, ‘easy’ to ‘complex,’ and specialty to primary care. Each carries its own unique challenges, but also alliance portfolio challenges as well. In addition, new alliance models, such as clinical collaborations, are emerging, furthering complexity. This session discusses concepts of alliance portfolio management.

»5:15 KEYNOTE PRESENTATION: AbbVie, a New Type of Company; a New Model for Alliance Management

Anna Maroney, Ph.D., Vice President, Head, Alliance Management, AbbVieAs a new biopharmaceutical company, AbbVie brings together the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur. This new model requires innovative ways of thinking about alliance management. Beyond relationships and governance to creating true value, this new model brings alliance management into the partnership in a way that ensures accountability, aligned goals and pro-active risk mitigation planning. The presentation will describe the journey of building and enabling alliance management to deliver the greatest value to the company and our partnerships.

6:00 - 7:00 Welcome Reception in the Exhibit Hall (Sponsorship Opportunity Available)

Cover

Agenda



REGISTER NOW


Short Courses









Day 2 - TUESDAY, MAY 6

7:30 am Morning Coffee

8:00 Interactive Breakout Discussion Groups and Speed NetworkingGrab a cup of coffee and delve deeper into some of the overarching concerns facing alliances today. These are moderated round tables with brainstorming and interactive problem solving, allowing conference participants from diverse backgrounds to have frank discussion while exchanging ideas, experiences, and developing future collaborations around a focused topic.

AM Insights: Initial Activities Impacting Alliance Success

9:25 Chairperson’s Opening RemarksNick Dunscombe, Head, Global Alliance Management, Centre of Excellence, AstraZeneca

9:30 Is It Preferred to Have Formally Established Alliance Management?Andrea Matthews, Vice President, Operations and Alliance Management, SelventaThe responsibilities of alliance management can be formally defined by the contractual agreement between two parties. Alternatively, alliance management responsibilities can be less defined and happen more informally between two companies. We will compare two case studies and the associated advantages and disadvantages of formal or informal governance for alliance management. We will also review recommendations that can contribute to success for each situation as well as potential areas to keep an eye on.

10:00 Living with a Master AgreementOsama Nabulsi, Vice President, Business Development and Alliance Management, HIKMA PharmaceuticalsAlliance management of a partnership that is dictated by an umbrella agreement is a double-edged sword: long life agreement and an ever changing environment. Alliance in this case requires not only teams’ diligence and execution but also an organizational commitment. This is a unique case study of a multiple biosimilar product partnership that is significant for the industry as its execution mandates a strong alliance and flawless execution.


11:00 Reflections on an Alliance Launch: What Went Surprisingly Well and What Caught Us by SurpriseTroy Windt, Senior Director, Alliance Management and Business Development, Reata PharmaceuticalsNow that time has passed and the alliance is maturing, can you see the connections between the launch activities and the alliance successes? Knowing that once a deal is struck the natural tendency will be to get to work on the project activities; alliance management must prioritize on the most critical elements of “how” the teams, steering committees and executives will work together. This presentation will discuss real life experiences of this process and describe which alliance behaviors and processes instilled at launch led to productive performance later in the relationship. Further, we’ll take a look at the price that might have been paid by not attending ourselves to de-prioritized details during launch.

»11:30 KEYNOTE PRESENTATION: Alliance Evolution: From Just Signing a License to Getting Beyond the Deal

Frank Grams, Ph.D., Vice President, Head, Alliance Management & Transactions, SanofiThis presentation will discuss the changing alliance landscape, learnings from other Pharma and industries, the Sanofi case study of building an effective Alliance Management organization, and the way forward.

12:15 pm Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own

AM in ActionThis section explores the practical utilization of alliance management throughout a variety of partnership types, models and strategies. While the previous section focused on refining the management role, these skills are put into practice and leveraged throughout this series of discussions.

1:25 Chairperson’s Opening Remarks (Sponsorship Opportunity Available)

1:30 INTERACTIVE PANEL DISCUSSION: Improving Healthcare - Integration of Supply, Demand, and Regulation to Accelerate Commercialization and Market AcceptanceBCA has an innovative partnership model by accelerating access/commercialization to the following key Healthcare sectors: Hospitals, Blood Transfusion/Management, and the Healthy Donor community. The model also includes collaboration with the FDA to create efficient pathways for developing technologies that have the potential to create a safer blood supply. As part of this relationship, BCA members work closely with Cellular Therapy and Biologic companies developing new blood based technologies for commercialization. This discussion will bring an innovative approach in partnership involving sectors of markets that were not considered or utilized before to develop and accelerate commercialization of therapeutics, diagnostics and healthcare products for the benefit of society.Moderator: Neil Dey, Ph.D., MBA, COO, Lana Management & Business Research InternationalPanelists: Bill Block, President & CEO, Management, Blood Centers of AmericaDavid Perez, President & CEO, Terumo BCTErik Woods, Ph.D., President and CEO, Cook General BiotechnologiesC.D. Atreya, Ph.D., Associate Director, Research, OBRR, CBER, FDA

2:30 Alliance Management Best Practices - Lessons Learned from a Small with Large Pharma CollaborationMaryAnne McCarthy, Executive Director, Clinical Operations and Alliance Management, Incyte CorporationKimberly Koch, Alliance Manager, Eli Lilly and CompanyI will provide an overview of how to streamline alliance team interactions by taking the time to establish an ‘Alliance Infrastructure’ that includes identification of joint objectives, addressing corporate culture differences, and properly implementing governance and communication plans. I will highlight challenges and how they can be managed utilizing the established alliance Infrastructure. I will also touch on the value of alliance surveys and making adjustments on the fly.


Cover

Agenda



REGISTER NOW


Short Courses









Moving toward Partner of Choice: Strategies for Standing Out

3:30 Co-Presentation: Successful Biopharma Partnerships with FoundationsAllison Formal, Vice President, Research & Business Development, The Leukemia & Lymphoma Soc (LLS)Jason Rhodes, President & CFO, EpizymeThe Leukemia & Lymphoma Society successfully partnered with Avila, Epizyme, Oconova, Celator, Acetylon and others which enabled them to raise funding and go to public markets or partner their technologies with larger commercial pharma companies. This co-presentation will discuss our unique model using our partnership with Epizyme as a case study.

»4:15 KEYNOTE PRESENTATION: Building an Alliance Management Culture and Capabilities within Your Company - It Goes a Long Way to Foster Healthy Collaborations and to Be a Preferred Partner

Knut Sturmhoefel, Ph.D., Head, Alliance Management, Global Business Development & Licensing, Novartis

5:00 End of Day and Dinner Short Course Registration

5:30 – 8:30 Dinner Short Course (See page 3 for details)*

Day 3 - WEDNESDAY, MAY 7

7:45 am Morning Coffee

Strategic Partnerships: Reinventing the Drug Development Paradigm

8:25 Chairperson’s Opening RemarksTeri Melese, Ph.D., Associate Adjunct Professor, Rady School of Management; Assistant Vice Chancellor, Industry Research Alliances, University of California, San Diego

8:30 Drug Development Yesterday, Today and Tomorrow - Business Model EvolutionMagnus R. Björsne, Ph.D., MBA, Business Development Transaction Director, AstraZenecaThe pharma landscape has changed dramatically during the last decade and I will provide a perspective of the future interplay between academia, SMEs, venture capital and big pharma. In a sometimes divergent fashion, key players in the value chain have changed their strategies and what are the risks and opportunities emerging out of this?

9:00 Open Innovation-Based Drug Discovery: A Promising Precompetitive ParadigmRathnam Chaguturu, Ph.D., Senior Director, Discovery Sciences, SRI InternationalResurgence of the pharmaceutical industry to its preeminence can only be realized through Collaborative Innovation in Biomedicine. These are challenging times, but they also offer unprecedented opportunities to form complementary and synergistic partnerships and collaborative research enterprises with an overarching goal of advancing drug discovery breakthroughs and bridge the translational gap. Stakeholders must engage in a partnership, where the core missions of each institution are recognized, respected and accommodated. The talk highlights innovative partnership models, and elucidates the changing landscape in drug discovery as ever more promising, and perhaps the colloquial herding the cats may be not that impossible.

9:30 CASE STUDY: How Public, Government and Private Investments Led to a Game-Changing Strategic Partnership that Leverages the Creative, Revolutionary Thinking of an Academic with the Delivery Power of an Innovative Pharma CompanyMark Coflin, Executive Director, Business Development and Licensing, Alliance Management, Novartis Pharmaceuticals CorporationDavid Tollerud, Ph.D., COO, RegenerexNovartis and Regenerex have recently formed a research alliance to advance novel cell therapy to treat conditions with high unmet need. This presentation will discuss a strategic state investment that brought a translational research institute including 23 families to form the foundation for rapid expansion of federally funded research at the University of Louisville. A Biotech start-up company, Regenerex LLC was formed to promote R&D activities and ultimately commercialization of the platform technology funded largely by federal (NIH) and state small business grants. Regenerex and the University formed a highly successful public/private partnership that supported several successful clinical trials and carried the flagship tolerance trial to FDA late Phase II. These clinical trial results formed the basis for a strategic global partnership between Regenerex and Novartis that includes basic and translational research initiatives as well as clinical trials to deliver an innovative portfolio of novel cell therapy therapeutics to treat patients in need.


Cover

Agenda



REGISTER NOW


Short Courses









10:45 INTERACTIVE PANEL DISCUSSION: Optimizing the Impact of Academic-Industry Alliances on InnovationModerator: Teri Melese, Ph.D., Associate Adjunct Professor, Rady School of Management; Assistant Vice Chancellor, Industry Research Alliances, University of California, San DiegoOver the past decade strategic alliances have become a critical business strategy for both public and private organizations. The panel will focus on innovation and the different strategies or thinking within companies about the role/value of company/university collaborations in fostering and supporting innovation. What lessons have been learned that allow us to maximize the value and mutual benefit of these partnerships? Apart from the short-term goals how have we structured partnerships to have a longer term fundamental change to our approaches to bringing products to market, especially with respect to developing disease interventions? What new thinking in the legal framework might be required to successfully catalyze the new open innovation models.Panelists:Anthony Marshall, Global CEO, Study Program Director; Leader, Strategy and Transformation Institute for Business Value, IBMSylvaine Cases, Director, External Innovation, Sanofi-AventisYvonne Tran, Vice President & General Counsel, Schrödinger, Inc.Noah Leibowitz, J.D., Partner, Intellectual Property Group and Litigation Department, Simpson Thacher & Bartlett LLP

11:45 Enjoy Lunch on Your Own

Refining Service-Based and Diagnostic Partnerships

12:55 pm Chairperson’s Opening RemarksRathnam Chaguturu, Ph.D., Senior Director, Discovery Sciences, SRI International

1:00 Alliance Management’s Role in Narrowing the Gap between Drug and DeviceDavid Kern, Senior Director, Regulatory, Myraqa, Inc.With the rise of personalized medicine comes an explosion in the number of biomarkers being developed as companion diagnostics. Aligning the goals and timelines of a drug and diagnostic has always been a challenge, but with some therapeutics now getting breakthrough status, the task is even more difficult. Alliance Management can play a key role in taking a test through clinical trials and FDA approval as swiftly and painlessly as possible by making sure that both sides stay in constant communications and that all the risks are being adequately addressed throughout the process.

1:30 What CROs Look for in Pharmaceutical, Medical Device and Diagnostics PartnersAdam Ruskin, Ph.D., Vice President, Clinical Development, LabCRO, Inc.At some point most pharmaceutical, medical device and diagnostic companies look for a CRO partner. However, what the CRO is looking for in partner companies is not typically what the pharma/device company is looking for. As a pharma/device company there are certain items that potential CRO partners look for, and more importantly, certain items that they do not want in their partner companies.

2:00 Building and Maintaining Pharma-CRO Partnerships Focused on Early Discovery and Preclinical Drug DevelopmentRob Lobell, Director, Sourcing Operations, MerckOver the past decade, Merck & Co. has shifted its early phase drug discovery model from a position where most of the work was done with in-house resources to its current state, where a significant percentage of the work is executed using external resources. A key component of this strategy has been the building of a focused set of collaborations with Contract Research Organizations that can supply research activities across a range of functional areas critical to early drug discovery and development. This operational model has been enabled by a Sourcing Operations group that serves in a coordinating capacity to link research teams and other research support functions at Merck with their counterparts at the CRO partners. Members of the Sourcing Operations group serve as relationship managers with the CRO partners, and employ a governance framework and set of processes for managing and building the partnership, resolving issues, evaluating partner performance, and building research capabilities. The application of this working model of Alliance Management to one of Merck’s key CRO partnerships will be discussed.

2:30 Close of Conference

Cover

Agenda



REGISTER NOW


Short Courses









CHI offers comprehensive packages that can be customized to your budget and objectives. Sponsorship allows you to achieve your goals before, during, and long after the event. Packages may include presentations, exhibit space and branding, as well as the use of delegate lists. Signing on early will maximize your exposure to qualified decision-makers and drive traffic to your website in the coming months.

Podium Presentations— Available within Main Agenda! Showcase your solutions to a guaranteed, targeted audience through a 15- or 30-minute presentation during a specific conference program, breakfast, lunch, or separate from the main agenda within a pre-conference workshop. Package includes exhibit space, on-site branding, and access to cooperative marketing efforts by CHI. For the luncheon option, lunches are delivered to attendees who are already seated in the main session room. Presentations will sell out quickly, so sign on early to secure your talk!

Invitation-Only VIP Dinner/Hospitality Suite Select specific delegates from the pre-registration list to attend a private function at an upscale restaurant or a reception at the hotel. From extending the invitations, to venue suggestions, CHI will deliver your prospects and help you make the most of this invaluable opportunity.

Focus Group CHI will gladly provide you the opportunity of running a focus group on-site. This exclusive gathering can be useful to conduct market research, collect feedback on a new product idea, and collect marketing intelligence from industry experts on a specific topic.

User Group Meeting/Custom Event Co-locate your user group meeting or custom event. CHI will help market the event, manage logistical operations, develop the agenda, and more. CHI can handle the entirety of the meeting or select aspects.

Exhibit Exhibitors will enjoy facilitated networking opportunities with qualified delegates, making it the perfect platform to launch a new product, collect feedback, and generate new leads. Exhibit space sells out quickly, so reserve yours today!

Additional branding and promotional opportunities are available!

Looking for additional ways to drive leads to your sales team? One move can make all the difference!CHI’s Lead Generation Programs will help you obtain more targeted, quality leads throughout the year. We will mine our database of 800,000+ life science professionals to your specific needs. We guarantee a minimum of 100 leads per program! Opportunities include Whitepapers, Web Symposia, Custom Market Research Surveys, and Podcasts. Please Note: Advertising opportunities such as marketing and promotional emails are also available.

For more information, please contact: Jay MulhernBusiness Development Manager781-972-1359 | [email protected]

SPONSOR INFORMATION HOTEL & TRAVELConference Hotel: Discounted Room Rate: $219 s/dLoews Philadelphia Hotel Discounted Room Rate Cut-off Date: April 7, 20141200 Market StreetPhiladelphia, PA 19107Hotel WebsiteTel: 215-627-1200

Please visit our conference website to make your reservation online or you may call the hotel directly to reserve your sleeping accommodations. You will need to identify yourself as a Cambridge Healthtech Institute conference attendee to receive the discounted room rate with the host hotel. Reservations made after the cut-off date or after the group room block has been filled (whichever comes first) will be accepted on a space-and-rate-availability basis. Rooms are limited, so please book early.

Flight Discounts:Special discount rates have been established with American Airlines for this conference.To receive a 5% or greater discount on all American Airline flights please use one of the following methods:• Call America Airlines directly at 1-800-433-1790 (authorization code 7654AA).• Go online at www.aa.com/group (enter 7654AA in promotion discount box).• Contact our designated travel agent Rona Meizler at 617-559-3735 or Rona.Meizler@

protravelinc.com

Car Rental Discounts:Special discount rentals have been established with Hertz for this conference. Please use one of the following methods:Click here to make your reservation use our Hertz Convention Number (CV): 04KL0005Call Hertz directly at 800-654-3131 use our Hertz Convention Number (CV): 04KL0005

Top Reasons to Stay at Loews Philadelphia Hotel:• Complimentary internet available in guest rooms• Conveniently located within walking distance to many historical sights as well as

shopping and restaurants• No commute as conference is located in the hotel• Only 20 minutes from Philadelphia International Airport• Opportunity for after hours networking with your peers

Cover

Agenda



REGISTER NOW


Short Courses



Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, MA 02494www.healthtech.com


8

https://www.hertz.com/rentacar/reservation/?id=22407





ADDITIONAL REGISTRATION DETAILSEach registration includes all conference sessions, posters and exhibits, food functions, and access to the conference proceedings link.Handicapped Equal Access: In accordance with the ADA, Cambridge Healthtech Institute is pleased to arrange special accommodations for attendees with special needs. All requests for such assistance must be submitted in writing to CHI at least 30 days prior to the start of the meeting.To view our Substitutions/Cancellations Policy, go to www.healthtech.com/regdetailsVideo and or audio recording of any kind is prohibited onsite at all CHI events.

Complimentary news delivered to your inbox

A series of diverse reports designed to keep life science professionals informed of the salient trends in pharmaceutical technology, business, clinical development, and therapeutic disease markets.For a detailed list of reports, visit InsightPharmaReports.com, or contact Rose LaRaia, [email protected], +1-781-972-5444.

Barnett is a recognized leader in clinical education, training, and reference guides for life science professionals involved in the drug development process. For more information, visit barnettinternational.com.

Cambridge Healthtech Associates™ (CHA™) leverages its extensive network and unique collaborative model in consulting, technology evaluations and community-based communication services to help clients in the life sciences industry commercialize and penetrate the marketplace to increase revenue. Visit www.chacorporate.com.

SHORT COURSES Commercial

One short course $699Two short courses $999

CONFERENCE PRICING

STANDARD PACKAGE (Includes access to 1 conference, excludes short courses)

Registrations after April 4, 2014, and on-site $2695

CONFERENCE DISCOUNTS

Colleague Discount - Save 15% when you book with a colleague! Individuals must register for the same conference and submit completed registration forms together for discount to apply. Group booking discounts cannot be combined with any other discounts.

REGISTER 3 - 4th IS FREE: Individuals must register for the same conference or conference combination and submit completed registration form together for discount to apply.

Alumni Discount: Cambridge Healthtech Institute (CHI) appreciates your past participation at Strategic Alliance Management Congress. As a result of the great loyalty you have shown us, we are pleased to extend to you the exclusive opportunity to save an additional 20% off the registration rate.

Group Discounts: Discounts are available for multiple attendees from the same organization. For more information on group rates contact David Cunningham at +1-781-972-5472

If you are unable to attend but would like to purchase the Strategic Alliance Management Congress CD for $350 (plus shipping), please visit Healthtech.com/AMS. Massachusetts delivery will include sales tax.

How to Register: Healthtech.com/[email protected] • P: 781.972.5400 or Toll-free in the U.S. 888.999.6288

Please use keycode AMS F when registering

Subscribe to New Bulletins or the Weekly Update Newsletter at Bio-ITWorld.com

Clinical Trials to the Clinic, subscribe at ClinicalInformaticsNews.com

11th Annual

ALLIANCE STRATEGIC

MANAGEMENT CONGRESSAdvancing Pharmaceuticals through

Collaborations & Partnerships

May 5-7, 2014Loews Philadelphia HotelPhiladelphia Downtown

Cover

Agenda



REGISTER NOW


Short Courses



Cambridge Healthtech Institute, 250 First Avenue, Suite 300, Needham, MA 02494www.healthtech.com


“I am happy to have made the long trip. It was worth it.”- Alliance Manager, Dr. Reddy Laboratories

http://www.healthtech.com/regdetails

http://www.insightpharmareports.com/

mailto:rlaraia%40healthtech.com?subject=

http://www.barnettinternational.com/

http://www.chacorporate.com


mailto:reg%40healthtech.com?subject=





Cover Conference-at-a-Glance Annual STRATEGIC ALLIANCECorporate Development Project Management...

Documents

Transcript of Cover Conference-at-a-Glance Annual STRATEGIC ALLIANCECorporate Development Project Management...